Integra LifeSciences to Present at the 22nd Annual Morgan Stanley Healthcare Conference
Rhea-AI Summary
Integra LifeSciences (NASDAQ: IART), a leading global medical technology company, has announced its participation in the 22nd Annual Morgan Stanley Healthcare Conference. Lea Knight, the company's chief financial officer, is scheduled to present on September 6, 2024, at 10:45am ET.
The presentation will be accessible via a live webcast on Integra LifeSciences' investor relations website. This event provides an opportunity for investors and analysts to gain insights into the company's recent developments, financial performance, and future outlook within the healthcare technology sector.
Integra LifeSciences' participation in this prestigious conference underscores its commitment to engaging with the investment community and showcasing its position in the medical technology market.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, IART declined 0.72%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
PRINCETON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the Morgan Stanley Healthcare conference on September 6, 2024 at 10:45am ET.
A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at https://investor.integralife.com/events-and-presentations.
About Integra LifeSciences
At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic, and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit investor.integralife.com.
Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com
Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com
Integra LifeSciences Holdings Corporation